Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees De Joncheere

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Health Policy (Amsterdam, Netherlands)|October 11, 2016
Policy interventions related to medicines: Survey of measures taken in European countries during 2010-2015Sabine Vogler, Nina Zimmermann, Kees de Joncheere
Southern Med Review|October 25, 2012
Pharmaceutical policies in European countries in response to the global financial crisisSabine Vogler, Nina Zimmermann, Christine Leopold, et al.
BMJ (Clinical Research Ed.)|September 19, 2014
On WHO's essential medicines process and transparencyNicola Magrini, Jane Robertson, Kees de Joncheere, et al.
Globalization and Health|May 8, 2015
Medicines availability for non-communicable diseases: the case for standardized monitoringJane Robertson, Cécile Macé, Gilles Forte, et al.
Globalization and Health|August 7, 2015
Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoringJane Robertson, Cécile Macé, Gilles Forte, et al.
Lancet (London, England)|September 6, 2003
Ensuring ethical drug promotion--whose responsibility?Jonathan D Quick, Hans V Hogerzeil, Lembit Rägo, et al.
Plos Medicine|June 1, 2016
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic AnalysisSwathi Iyengar, Kiu Tay-Teo, Sabine Vogler, et al.
Bulletin of the World Health Organization|August 1, 2015
Tough decisions on essential medicines in 2015Nicola Magrini, Jane Robertson, Gilles Forte, et al.
Health Policy (Amsterdam, Netherlands)|October 22, 2011
Differences in external price referencing in Europe: a descriptive overviewChristine Leopold, Sabine Vogler, A K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)|September 25, 2013
Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Health Policy (Amsterdam, Netherlands)|October 11, 2016
Policy interventions related to medicines: Survey of measures taken in European countries during 2010-2015Sabine Vogler, Nina Zimmermann, Kees de Joncheere
Southern Med Review|October 25, 2012
Pharmaceutical policies in European countries in response to the global financial crisisSabine Vogler, Nina Zimmermann, Christine Leopold, et al.
BMJ (Clinical Research Ed.)|September 19, 2014
On WHO's essential medicines process and transparencyNicola Magrini, Jane Robertson, Kees de Joncheere, et al.
Globalization and Health|May 8, 2015
Medicines availability for non-communicable diseases: the case for standardized monitoringJane Robertson, Cécile Macé, Gilles Forte, et al.
Globalization and Health|August 7, 2015
Erratum to: Medicines availability for non-communicable diseases: the case for standardized monitoringJane Robertson, Cécile Macé, Gilles Forte, et al.
Lancet (London, England)|September 6, 2003
Ensuring ethical drug promotion--whose responsibility?Jonathan D Quick, Hans V Hogerzeil, Lembit Rägo, et al.
Plos Medicine|June 1, 2016
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic AnalysisSwathi Iyengar, Kiu Tay-Teo, Sabine Vogler, et al.
Bulletin of the World Health Organization|August 1, 2015
Tough decisions on essential medicines in 2015Nicola Magrini, Jane Robertson, Gilles Forte, et al.
Health Policy (Amsterdam, Netherlands)|October 22, 2011
Differences in external price referencing in Europe: a descriptive overviewChristine Leopold, Sabine Vogler, A K Mantel-Teeuwisse, et al.
Health Policy (Amsterdam, Netherlands)|September 25, 2013
Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countriesChristine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, et al.
Pageof 2